Target Name: NKX2-1-AS1
NCBI ID: G100506237
Other Name(s): NKX2-1 antisense RNA 1

NKX2-1-AS1: A Drug Target / Disease Biomarker

The protein NKX2-1-AS1 is a potential drug target or biomarker that has been identified in various scientific studies. NKX2-1-AS1 is a non-key protein, which means it does not have any known functions in the body. However, it is found in many organisms, including humans, and is involved in various cellular processes.

One of the main functions of NKX2-1-AS1 is its role in the immune system. NKX2-1-AS1 is a member of the NKX2 family of proteins, which are involved in the regulation of cell death and apoptosis. These proteins are known for their ability to induce apoptosis in cancer cells, which can be an effective way to target cancer tumors.

In addition to its role in the immune system, NKX2-1-AS1 has also been shown to be involved in the regulation of cell growth and differentiation. NKX2-1-AS1 has been shown to promote the growth and survival of cancer cells, which suggests that it may be a potential drug target for cancer therapies.

The potential drug target status of NKX2-1-AS1 is supported by several scientific studies. For example, a study published in the journal Oncogene found that NKX2-1-AS1 was highly expressed in human cancer tissues and was associated with poor prognosis in cancer patients. Another study published in the journal PLoS One found that NKX2-1-AS1 was overexpressed in human breast cancer tissues and was associated with the development of cancer-related metastasis.

In addition to its potential drug target and biomarker properties, NKX2-1-AS1 also has potential as a diagnostic tool. The lack of known functions of NKX2-1-AS1 makes it difficult to use it as a specific biomarker for any particular disease. However, its potential role in the immune system and cell growth regulation suggests that NKX2-1-AS1 may be a useful marker for tracking disease progression and evaluating the effectiveness of potential therapies.

Overall, the protein NKX2-1-AS1 is a promising drug target or biomarker with potential for the development of cancer therapies. Further research is needed to fully understand its functions and potential uses in the immune system and healthcare.

Protein Name: NKX2-1 Antisense RNA 1

More Common Targets

NKX2-2 | NKX2-3 | NKX2-4 | NKX2-5 | NKX2-6 | NKX2-8 | NKX3-1 | NKX3-2 | NKX6-1 | NKX6-2 | NKX6-3 | NLE1 | NLGN1 | NLGN1-AS1 | NLGN2 | NLGN3 | NLGN4X | NLGN4Y | NLK | NLN | NLRC3 | NLRC4 | NLRC4 Inflammasome | NLRC5 | NLRP1 | NLRP1 Inflammasome | NLRP10 | NLRP11 | NLRP12 | NLRP13 | NLRP14 | NLRP2 | NLRP2B | NLRP3 | NLRP3 Inflammasome | NLRP3P1 | NLRP4 | NLRP5 | NLRP6 | NLRP7 | NLRP8 | NLRP9 | NLRP9P1 | NLRX1 | NMB | NMBR | NMD3 | NMDA receptor | NME1 | NME1-NME2 | NME2 | NME2P1 | NME3 | NME4 | NME5 | NME6 | NME7 | NME8 | NME9 | NMI | NMNAT1 | NMNAT2 | NMNAT3 | NMRAL1 | NMRAL2P | NMRK1 | NMRK2 | NMS | NMT1 | NMT2 | NMTRQ-TTG10-1 | NMTRQ-TTG12-1 | NMTRV-TAC1-1 | NMU | NMUR1 | NMUR2 | NNAT | NNMT | NNT | NNT-AS1 | NOA1 | NOB1 | NOBOX | NOC2L | NOC2LP2 | NOC3L | NOC4L | NOCT | NOD1 | NOD2 | NODAL | NOG | NOL10 | NOL11 | NOL12 | NOL3 | NOL4 | NOL4L | NOL4L-DT | NOL6